Nationwide cohort study finds a possible protective link between aspirin use and reduced HCC in MASLD, suggesting potential benefits that warrant further validation.
Findings from both population-based and genetic analyses suggest a possible protective association between aspirin use and HCC in patients with MASLD, which warrants further validation.
No takes yet. Share an insight, caveat, or question.
Ahn et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: